Sage Journals: Discover world-class research

Open access

Research article

First published 2021

Highly prevalent Russian HIV-1 V3-loop sequence variants are susceptible to maraviroc

ME Lewis, B Jubb, P Simpson [...]

Antiviral Chemistry and Chemotherapy

Open access

Research article

First published 2021

V3-Loop genotypes do not predict maraviroc susceptibility of CCR5-tropic virus or clinical response through week 48 in HIV-1–infected,treatment-experienced persons receiving optimized background regimens

ME Lewis, P Simpson, J Mori [...]

Antiviral Chemistry and Chemotherapy

Free access

Research article

First published 2011-4

Baseline CD4 + T-cell counts and weighted background susceptibility scores strongly predict response to maraviroc regimens in treatment-experienced patients

Jonathan M Schapiro, Charles AB Boucher, Daniel R Kuritzkes [...]

Antiviral Therapy

Retricted access

Research article

First published 2012-05

Susceptibility of HIV Type 2 Primary Isolates to CCR5 and CXCR4 Monoclonal Antibodies,Ligands,and Small Molecule Inhibitors

Maria Espirito-Santo, Quirina Santos-Costa, Marta Calado [...]

AIDS Research and Human Retroviruses

Open access

Research article

First published 2019

Incidence of CXCR4 tropism and CCR5-tropic resistance in treatment-experienced participants receiving maraviroc in the 48-week MOTIVATE 1 and 2 trials

Becky Jubb, Marilyn Lewis, Lynn McFadyen [...]

Antiviral Chemistry and Chemotherapy

Retricted access

Research article

First published 2016-07

HIV-1 Group O Genotypes and Phenotypes: Relationship to Fitness and Susceptibility to Antiretroviral Drugs

Denis M. Tebit, Hamish Patel, Annette Ratcliff [...]

AIDS Research and Human Retroviruses

Free access

Research article

First published 2013-11

Hypersensitivity and Desensitization to Darunavir in a Case of HIV Infection with Triple-Class Drug Resistance

Margalit Lorber, Salim Haddad

Journal of the International Association of Providers of AIDS Care (JIAPAC)

Retricted access

Research article

First published 2010-12

Evaluation of Primary Resistance to HIV Entry Inhibitors Among Brazilian Patients Failing Reverse Transcriptase/Protease Inhibitors Treatment Reveal High Prevalence of Maraviroc Resistance-Related Mutations

Cecília S. Alencar, Anna S. Nishiya, Suzete Ferreira [...]

AIDS Research and Human Retroviruses

Open access

Research article

First published 2023-12

Cross-resistance to entry inhibitors and lenacapavir resistance through Week 52 in study CAPELLA

Nicolas Margot, Nina Pennetzdorfer, Vidula Naik [...]

Antiviral Therapy

Free access

Review article

First published 2005-12

CCR5 Antagonists: Host-Targeted Antivirals for the Treatment of HIV Infection

Mike Westby, Elna van der Ryst

Antiviral Chemistry and Chemotherapy

Search results